Sabra Health Care REIT, Inc. (SBRA)

NASDAQ • Real Estate

$20.78

-$0.14 (-0.7%)

Market closed

Last close at September 4, 2026 at 20:00 UTC

Day Range$20.65 - $21.19

Avg. Volume (3M)2M

Market Cap$5.2B

P/E Ratio79.9

52 Week Range

$17.17$22.77

Next EarningsIn 61 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026

Revenueeverything earned$235.8M100%

Gross Profitminus cost of goods$235.8M100%

In plain terms: out of every $100 in revenue, Sabra Health Care REIT, Inc. currently loses $11.

Fundamentals & Financials

Revenue (TTM)

$859.5M

Net Income (TTM)

$65.4M

EPS (TTM)

$0.26

ROA (TTM)

1.19%

Current Ratio

43.68

Dividend Yield

1.54%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings

+55.6%Q3 2025$0.28

-48.7%Q4 2025$0.09

-35.3%Q1 2026$0.11

-4.0%Q2 2026$0.16

-158.4%Q3 2026-$0.1

Nov 4

in 61 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026

Miss -158.4%

Sabra Health Care REIT’s revenue topped consensus in the second fiscal quarter of 2026, based on preliminary results reported August 3, 2026, with revenue of $235.9 million topping the $219.4 million estimate (+7.5%). Net interest income came in at about $5.8 million for the quarter, and the company paid roughly $75.7 million in dividends. For the next period, consensus calls for EPS of $0.17 on revenue of $232.6 million.

View full earnings history

About Sabra Health Care REIT, Inc.

Sabra Health Care REIT, Inc. is a real estate investment trust listed on the NASDAQ as SBRA that owns healthcare-property assets, with $774.6 million in revenue for FY2025. The company operates in healthcare real estate rather than property types like offices or apartments, and its public listing dates to April 2, 2002.

Name

Sabra Health Care REIT, Inc.

CEO

Richard K. Matros

Website

www.sabrahealth.com

Industry

Real Estate

Year Founded

2010

Employees

Today's Snapshot

AI-generated

SBRA closed 0.7% below yesterday's close, in line with a weaker sector.

Trading Volume

Above 10d avg 1.7M

1.8M

vs S&P 500 Today

Moderate Underperformance

-0.30%

Updated: September 4, 2026 at 20:15 UTC

Technical Indicators

6 Buy2 Neutral0 Sell

SBRA displays broad moving-average support with the price sitting at short-term averages and the 20–200 day series signaling buy, while momentum measures (CCI and a modest MACD edge) favor the upside and RSI is neutral. ADX is low, suggesting the trend lacks conviction, and OBV is negative which contrasts with the otherwise constructive trend; volatility is subdued. The nearby pivot is neutral, leaving price structure and momentum as the primary positives. Technical takeaway: strong buy stance driven by consistent bullish moving averages and supportive momentum despite weak trend strength.

All signals